๐ต๏ธ Citius Pharmaceuticals, Inc. ($CTXR)
SEC insider & ownership activity, last 12 months ยท CIK 1506251 ยท every row links its SEC filing
Insiders were quiet over the last 12 months โ no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Feb 9, 2026.
Insider flow
0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 13G | Feb 17, 2026 | filing โ | |
| Heights Capital Management, Inc. | 9.9% | 13G | Feb 17, 2026 | filing โ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jun 1, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing โ |
| Earnings (2.02) | May 15, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing โ |
| Material agreement (1.01) | May 4, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing โ |
| Unregistered equity sale (3.02) | Apr 23, 2026 | filing โ |
| Other events (8.01) | Apr 23, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Apr 23, 2026 | filing โ |
| Material agreement (1.01) | Apr 23, 2026 | filing โ |
| Other events (8.01) | Apr 23, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Apr 23, 2026 | filing โ |
| Shareholder vote (5.07) | Apr 6, 2026 | filing โ |
| Other events (8.01) | Mar 31, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing โ |
| Other events (8.01) | Mar 10, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing โ |
| Other events (8.01) | Mar 4, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Mar 4, 2026 | filing โ |
| Earnings (2.02) | Feb 9, 2026 | filing โ |
| Delisting notice (3.01) | Feb 9, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Feb 9, 2026 | filing โ |
| Earnings (2.02) | Dec 23, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing โ |
| Reg FD disclosure (7.01) | Dec 1, 2025 | filing โ |
| Other events (8.01) | Dec 1, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Dec 1, 2025 | filing โ |
| Reg FD disclosure (7.01) | Oct 23, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Oct 23, 2025 | filing โ |
| Material agreement (1.01) | Oct 20, 2025 | filing โ |